---
status: passed
---

# Phase 199 Verification

## Outcome

Phase `199` implemented one bounded reviewer-facing assurance lane with a
dedicated CLI surface, reviewer-population package generation, investigation
packaging, and regression coverage over the same Mercury truth artifacts.

## Evidence

- [main.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-mercury/src/main.rs)
- [commands.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-mercury/src/commands.rs)
- [cli.rs](/Users/connor/Medica/backbay/standalone/arc/crates/arc-mercury/tests/cli.rs)
- [README.md](/Users/connor/Medica/backbay/standalone/arc/docs/mercury/README.md)
- [ASSURANCE_SUITE.md](/Users/connor/Medica/backbay/standalone/arc/docs/mercury/ASSURANCE_SUITE.md)
- [ASSURANCE_SUITE_OPERATIONS.md](/Users/connor/Medica/backbay/standalone/arc/docs/mercury/ASSURANCE_SUITE_OPERATIONS.md)

## Validation

- `cargo fmt`
- `cargo check -p arc-mercury-core -p arc-mercury`
- `cargo test -p arc-mercury --test cli`

## Requirement Closure

`ASR-03` and `ASR-04` are now satisfied locally: Mercury can generate one
bounded reviewer-facing assurance export and investigation path for internal,
auditor, and counterparty review without turning Mercury into a generic portal
product.

## Next Step

Phase `200` can now validate the assurance lane, publish the operating model,
and close the milestone decision.
